<DOC>
	<DOCNO>NCT02677220</DOCNO>
	<brief_summary>The aim study investigate clinical benefit patient implant Nucleus® CI532 cochlear implant . The Nucleus® CI532 pre-curved , perimodiolar array , EA32 , introduce cochlea straighten sheath .</brief_summary>
	<brief_title>Implantation With Nucleus CI532 Cochlear Implant Adults</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Meet current cochlear implant criterion implant center 18 year old bilateral sensorineural hearing loss Limited benefit appropriate binaural hearing aid Moderate profound hear loss low frequency profound hear loss mid high frequency Preoperative unaided threshold 40 65 dB HL , inclusively , 250 Hertz ( Hz ) 500 Hz ear implant Fluent speaker language use assess clinical performance Evidence hearing loss prior age 5 Sensorineural severe profound hearing loss great 20 year 2000Hz Simultaneous bilateral implantation prior study Medical psychological condition contraindicate undergoing general anesthesia surgery Cochlear anomaly might prevent complete insertion electrode array Hearing impairment due lesion neuropathy acoustic nerve , VIII nerve , central auditory pathway Active middle ear infection Tympanic membrane perforation Unrealistic expectation Unwillingness inability co comply investigational requirement Patients exist cerebral shunt drain Recurrent episodes bacterial meningitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>